Segawa's disease: Dopa-responsive dystonia

International Journal of Clinical Practice

Volumn 62, Issue 6, 2008, Pages 943-946

  Gordon, N ^a  

^a Children's Hospitals   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE; GUANOSINE TRIPHOSPHATE CYCLOHYDROLASE I; LEVODOPA; TETRAHYDROBIOPTERIN;

AUTOSOMAL DOMINANT INHERITANCE; BIOSYNTHESIS; CEREBROSPINAL FLUID ANALYSIS; CHROMOSOME 11; CHROMOSOME 14; DOPAMINE METABOLISM; DRUG MEGADOSE; DYSTONIA; ENZYME ACTIVATION; GENE MAPPING; GENE MUTATION; HUMAN; LIVER BIOPSY; PRIORITY JOURNAL; PROTEIN DEFICIENCY; REVIEW; SEGAWA DISEASE; URINALYSIS;

DOPAMINE AGENTS; DYSTONIC DISORDERS; GTP CYCLOHYDROLASE; HUMANS; LEVODOPA; MUTATION;

EID: 43949114210     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/j.1742-1241.2007.01319.x     Document Type: Review

References (28)

1. Ichinose H, Nagatsu T. Molecular genetics of hereditary progressive dystonia (HPD) (Segawa disease). Nippon Rinsho 1996 54 : 1453 9.
2. Bianca S, Bianca M. A new deletion in autosomal dominant guanosine triphosphate cyclohydrolase 1 deficiency gene - Segawa disease. J Neural Transm 2006 113 : 159 62.
3. Lüdecke B. Dwornieczak B, Bartholomé K. A point mutation in the tyrosine hydrolase gene associated with Segawa's syndrome. Hum Genet 1995 95 : 123 5.
4. Deonna T. DOPA-sensitive progressive dystonia of childhood with fluctuations of symptoms - Segawa's syndrome and possible variants. Results of a collaborative study of the European Federation of Child Neurology Societies (EFCNS). Neuropediatrics 1986 17 : 81 5.
5. Gordon N. Dopa-responsive dystonia: a widening spectrum. Dev Med Child Neurol 1996 38 : 554 9.
6. Van Hove JLK, Steyaert J, Matthijs G et al. Expanded motor and psychiatric phenotype in autosomal dominant Segawa syndrome due to GTP cyclohydrolase deficiency. J Neurol Neurosurg Psychiatry 2006 77 : 18 23.
7. Wang P-J, Ko Y-M, Ypunh C, Hwu W-L, Shen Y-Z. Hereditary progressive dystonia with marked diurnal fluctuation (Segawa syndrome) in Taiwan. Brain Dev 1994 16 : 126 31.
8. Priscu V, Lurie S, Savir I, Rabinerson D, Hagay Z. The choice of anesthesia in Segawa's syndrome. J Clin Anesth 1998 10 : 153 5.
9. Inchose H. Segawa's disease. Rinsho Shinkeigaku 2000 40 : 1284 6.
10. Pearl PL, Wallis DD, Gibson KM. Pediatric neurotransmitter diseases. Curr Neurol Neurosci Rep 2004 4 : 147 52.
11. Furukawa Y, Nygaard TG, Gütlich M et al. Striatal biopterin and tyrosine hydrolase protein reduction in dopa-responsive dystonia. Neurology 1999 63 : 1032 41.
12. Diepold K, Schütz B, Rostasy K et al. Levadopa-responsive infantile Parkinsonism due to a novel mutation in the tyrosine hydroxylase gene and exacerbation by virus infection. Mov Disord 2005 20 : 764 7.
13. Ichinose H, Suzuki T, Inagaki H, Ohye T, Nagatsu T. Molecular genetics of dopa-responsive dystonia. Biol Chem 1999 380 : 1355 64.
14. Harada T, Kagamiyama H, Hatakeyama K. Feedback regulation mechanisms for the control of GTP cyclohydrolase 1 activity. Science 1993 260 : 1507 10.
15. Ichinose H, Nagatsu T. Molecular genetics of hereditary dystonia-mutations in GTP cyclohydrolase 1 gene. Brain Res Bull 1997 43 : 35 8.
16. Segawa M, Nomura Y, Nishiyama N. Autosomal dominant guanosine triphosphate cyclohydrolase 1 deficiency (Segawa disease). Ann Neurol 2003 54 (Suppl. 6 S32 45.
17. Nagatsu T, Ichinose H. Regulation of pteridine-requiring enzymes by the cofactor tetrahydrobiopterin. Mol Neurobiol 1999 19 : 79 96.
18. Segawa M, Nomura Y, Nishiyama N. Autosomal dominant guanosine triphosphate cyclohydrolase 1 deficiency (Segawa disease). Ann Neurol 2003 54 (Suppl. 6 532 45.
19. Ichinose H, Inagaki H, Suzuki T, Ohye T, Nagatsu T. Molecular mechanisms of hereditary progressive dystonia with marked diurnal fluctuation, Segawa's disease. Brain Dev 2000 22 : S107 10.
20. Görke W, Bartholomé K. Biochemical and neurophysiological investigations in two forms of Segawa's disease. Neuropediatrics 1990 21 : 3 8.
21. Naylor EW, Ennis D, Davidson AGF, Wong LTK, Applegarth DA, Niederwieser A. Guanosine triphosphate cyclohydrolase 1 deficiency: early diagnosis by routine urine pteridine screening. Pediatrics 1987 79 : 374 8.
22. Blau N, Thöny B, Spada M, Ponzone A. Tetrahydrobiopterin and inherited hyperphenylalaninemias. Turk J Pediatr 1996 38 : 19 35.
23. Blau N, Ichinose H, Nagatsu T, Helzmann CW, Zacchello F, Burlia AB. A missense mutation in a patient with guanosine triphosphate cyclohydrolase 1 deficiency missed in the newborn screening program. J Pediatr 1995 126 : 401 5.
24. Dhondi J-l, Farrlaux J-p, Boudha A et al. Neonatal hyperphenylalaninemia presumably caused by guanosine triphosphate-cyclohydrolase deficiency. J Pediatr 1985 106 : 954 6.
25. Fletcher NA, Thompson PD, Scadding JW, Marsden CD. Successful treatment of childhood onset symptomatic dystonia with levodopa. J Neurol Neurosurg Psychiatry 1993 56 : 865 7.
26. Neville BGR, Parascandelo R, Farrugia R, Felice A. Sepiapterin reductase deficiency: a congenital dopa-responsive motor and cognitive disorder. Brain 2005 128 : 2291 6.
27. Nagatsu T, Ichinose H. GTP cyclohydrolase 1 gene, tetrohydrobiopterine, and tyrosine hydrolase gene: there relations to dystonia and Parkinsonism. Neurochem Res 1996 21 : 245 50.
28. Mink JW. Dopa-responsive dystonia in children. Curr Treat Options Neurol 2003 5 : 279 82.